{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:33:30Z","timestamp":1782135210632,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.oret.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T02:05:20Z","timestamp":1568167520000},"page":"164-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Objective Evaluation of Proliferative Diabetic Retinopathy Using OCT"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-5713","authenticated-orcid":false,"given":"Roy","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5311-4015","authenticated-orcid":false,"given":"Hagar","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8952-0659","authenticated-orcid":false,"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6685-4402","authenticated-orcid":false,"given":"Luke","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4155-9786","authenticated-orcid":false,"given":"Evgenia","family":"Anikina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Balaskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2019.09.004_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.pop.2015.05.005","article-title":"Diabetic retinopathy","volume":"42","author":"Hendrick","year":"2015","journal-title":"Prim Care"},{"key":"10.1016\/j.oret.2019.09.004_bib2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/eye.2014.320","article-title":"Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening","volume":"29","author":"Manjunath","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.oret.2019.09.004_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2014.09.041","article-title":"Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography","volume":"159","author":"Lee","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.004_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0161-6420(86)33697-2","article-title":"Fluorescein angiography complication survey","volume":"93","author":"Yannuzzi","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.09.004_bib5","first-page":"196","article-title":"Surgical management of retinal diseases: proliferative diabetic retinopathy and traction retinal detachment","volume":"Vol. 54","author":"Cruz-I\u00f1igo","year":"2014"},{"key":"10.1016\/j.oret.2019.09.004_bib6","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy","volume":"314","author":"Gross","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2019.09.004_bib7","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(17)31193-5","volume":"389","author":"Sivaprasad","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2019.09.004_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2009.01.024","article-title":"A\u00a0variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study","volume":"148","author":"Lalwani","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.004_bib9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/IAE.0000000000000869","article-title":"Optical coherence tomography features of active and inactive retinal neovascularization in proliferative diabetic retinopathy","volume":"36","author":"Vaz-Pereira","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.004_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/IAE.0b013e3182753b6f","article-title":"Retinal neovascularization secondary to proliferative diabetic retinopathy characterized by spectral domain optical coherence tomography","volume":"33","author":"Cho","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.004_bib11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/IAE.0000000000001336","article-title":"Tomographic relationships between retinal neovascularization and the posterior vitreous in proliferative diabetic retinopathy","volume":"37","author":"Vaz-Pereira","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.004_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2014.10.011","article-title":"Swept-source optical coherence tomography features of choroidal nevi","volume":"159","author":"Francis","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.004_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajo.2015.10.025","article-title":"Three-dimensional enhanced imaging of vitreoretinal interface in diabetic retinopathy using swept-source optical coherence tomography","volume":"162","author":"Adhi","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.004_bib14","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1097\/IAE.0000000000000881","article-title":"Optical coherence tomography angiography","volume":"35","author":"Spaide","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.004_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ajo.2018.05.018","article-title":"Characteristics of neovascularization in early stages of proliferative diabetic retinopathy by optical coherence tomography angiography","volume":"192","author":"Pan","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.004_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.diabres.2018.05.043","article-title":"New insights into diabetic retinopathy by OCT angiography","volume":"142","author":"Liu","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.oret.2019.09.004_bib17","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1097\/IAE.0000000000000716","article-title":"Optical coherence tomography angiography features of diabetic retinopathy","volume":"35","author":"Hwang","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.004_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/IAE.0000000000001938","article-title":"Vascular abnormalities in diabetic retinopathy assessed with swept-source optical coherence tomography angiography widefield imaging","volume":"39","author":"Schaal","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.004_bib19","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/IAE.0000000000000765","article-title":"Image artifacts in optical coherence angiography","volume":"35","author":"Spaide","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.004_bib20","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4103\/ijo.IJO_813_18","article-title":"Post-laser regression of diabetic neovascularization: an optical coherence tomography angiography study","volume":"66","author":"Shroff","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.004_bib21","first-page":"1528","article-title":"Bimodal imaging of proliferative diabetic retinopathy vascular features using swept source optical coherence tomography angiography","volume":"11","author":"Elbendary","year":"2018","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.004_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000485831","article-title":"Optical coherence tomography angiography of foveal neovascularization in diabetic retinopathy","volume":"9","author":"Andreanos","year":"2018","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.004_bib23","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1097\/IAE.0000000000001880","article-title":"Foveal retinal neovascularization in proliferative diabetic retinopathy","volume":"37","author":"Murakawa","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.004_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.21037\/qims.2018.09.02","article-title":"Ultra-wide optical coherence tomography angiography in diabetic retinopathy","volume":"8","author":"Zhang","year":"2018","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.oret.2019.09.004_bib25","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00417-018-3992-y","article-title":"Comparison between wide-angle OCT angiography and ultra-wide field fluorescein angiography for detecting non-perfusion areas and retinal neovascularization in eyes with diabetic retinopathy","volume":"256","author":"Sawada","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.004_bib26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0002-9394(98)00013-0","article-title":"The topographic distribution of the first sites of diabetic retinal neovascularization","volume":"125","author":"Feman","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.004_bib27","doi-asserted-by":"crossref","first-page":"8246","DOI":"10.1167\/iovs.12-10918","article-title":"Topographical distribution of retinal and optic disc neovascularization in early stages of proliferative diabetic retinopathy","volume":"53","author":"Jansson","year":"2012","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2019.09.004_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bjo.54.1.11","article-title":"Proliferative diabetic retinopathy. Site and size of initial lesions","volume":"54","author":"Taylor","year":"1970","journal-title":"Br J Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653019305548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653019305548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:27:46Z","timestamp":1762853266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653019305548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2468653019305548"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2019.09.004","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Objective Evaluation of Proliferative Diabetic Retinopathy Using OCT","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}